Neurodivergent Medication Survey
More than 600,000 people are affected by Epilepsy in the UK with some being forced to start rationing their meds. A national shortage of epilepsy medication is putting patients’ safety at risk, consultants have said.
The supply disruption of ADHD meds is caused by a combination of manufacturing issues and an increased global demand.
This is obviously a cause for concern.
Above are two questionnaires: one tailored for neurodiverse individuals who rely on medication to meet their support needs and another for this how provide care support.
Our objective is to unveil and document the ramifications of the shortage of medication utilised by neurodiverse adults. We aspire to evaluate the impact of these shortages on individuals and proffer suggestions on how to enhance the situation.
Our aim is to extend assistance to the charity’s members and facilitate healthcare providers in addressing this persisting issue. Additionally, we seek to harness our capacity to gather feedback for the pharmacy industry and encourage collaborative partnerships to ensure that this pivotal matter garners the attention it rightfully warrants.